Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin TherapeuticsGlobeNewswire (press release)Cancer immunotherapy research conducted by Dr. William Redmond at the Earle A. Chiles Research Institute at the Providence Cancer Center… Continue reading
Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin TherapeuticsNasdaqCancer immunotherapy research conducted by Dr. William Redmond at the Earle A. Chiles Research Institute at the Providence Cancer Center in Portland, Oregon wa… Continue reading
Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin TherapeuticsNasdaqCancer immunotherapy research conducted by Dr. William Redmond at the Earle A. Chiles Research Institute at the Providence Cancer Center in Portland, Oregon wa… Continue reading
Medical News Today |
Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells
News-Medical.net Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy, and radiation. A small subpopulation of tumor cells – glioma stem cells – is responsible for glioblastoma’s tumorigenesis, treatment … Brain tumor: New inhibitor may fight glioblastoma expansionMedical News Today |
|
Companies rush to develop “utterly transformative” gene therapies
HealthLeaders Media The approval of gene therapy for leukemia, expected in the next few months, will open the door to a radically new class of cancer treatments.Companies and universities are racing to develop these new therapies, which re-engineer and turbocharge … |